US Stock MarketDetailed Quotes

DARE Dare Bioscience

Watchlist
  • 4.2000
  • +0.7000+20.00%
Close Aug 13 16:00 ET
  • 4.2200
  • +0.0200+0.48%
Post 16:22 ET
35.89MMarket Cap-3620P/E (TTM)

Dare Bioscience Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
22.44K
9.3K
-71.92%2.81M
1.81M
1M
0
0
10M
0
0
Operating revenue
--22.44K
--9.3K
-71.92%2.81M
--1.81M
--1M
--0
--0
--10M
--0
--0
Cost of revenue
0
7.67K
0
0
Gross profit
22.44K
1.63K
0
0
Operating expense
-17.88%7.38M
-28.14%6.02M
-18.46%33.75M
-57.00%6.98M
31.62%9.4M
-6.51%8.99M
-0.21%8.38M
5.93%41.39M
70.08%16.23M
-43.65%7.14M
Selling and administrative expenses
-16.04%2.47M
-19.83%2.7M
7.71%12.11M
-2.35%3.08M
1.69%2.72M
4.53%2.95M
30.83%3.36M
33.04%11.24M
29.97%3.15M
19.68%2.68M
-General and administrative expense
-16.04%2.47M
-19.83%2.7M
7.71%12.11M
-2.35%3.08M
1.69%2.72M
4.53%2.95M
30.83%3.36M
33.04%11.24M
29.97%3.15M
19.68%2.68M
Research and development costs
-18.78%4.91M
-33.70%3.33M
-28.31%21.54M
-70.72%3.8M
49.58%6.67M
-11.09%6.04M
-13.53%5.02M
-1.88%30.04M
82.35%12.98M
-57.23%4.46M
Other operating expenses
----
----
0.00%100K
----
----
----
----
--100K
----
----
Operating profit
18.13%-7.36M
28.16%-6.02M
1.42%-30.94M
68.14%-5.17M
-17.62%-8.4M
-2,439.02%-8.99M
0.21%-8.38M
19.67%-31.39M
-70.08%-16.23M
43.65%-7.14M
Net non-operating interest income expense
Other net income (expense)
8,824.69%20.27M
-315.46%-732.88K
77.84%778.49K
-60.36%113.9K
-18.18%97.32K
665.35%227.12K
19,020.18%340.15K
17.55%437.75K
34,353.72%287.34K
7,787.93%118.95K
Other non- operating income (expenses)
8,824.69%20.27M
-315.46%-732.88K
77.84%778.49K
-60.36%113.9K
-18.18%97.32K
665.35%227.12K
19,020.18%340.15K
17,271.03%437.75K
34,353.72%287.34K
7,787.93%118.95K
Income before tax
247.34%12.91M
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
44.58%-7.02M
Income tax
Net income
247.34%12.91M
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
44.58%-7.02M
Net income continuous Operations
247.34%12.91M
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
44.58%-7.02M
Minority interest income
Net income attributable to the parent company
247.34%12.91M
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
44.58%-7.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
247.34%12.91M
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
44.58%-7.02M
Basic earnings per share
225.41%18.36
22.22%-0.84
5.41%-4.2
68.42%-0.72
-12.50%-1.08
-25,054.83%-14.64
10.00%-1.08
41.27%-4.44
-5.56%-2.28
55.56%-0.96
Diluted earnings per share
224.59%18.24
22.22%-0.84
5.41%-4.2
68.42%-0.72
-12.50%-1.08
-25,257.23%-14.64
10.00%-1.08
41.27%-4.44
-5.56%-2.28
55.56%-0.96
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 22.44K9.3K-71.92%2.81M1.81M1M0010M00
Operating revenue --22.44K--9.3K-71.92%2.81M--1.81M--1M--0--0--10M--0--0
Cost of revenue 07.67K00
Gross profit 22.44K1.63K00
Operating expense -17.88%7.38M-28.14%6.02M-18.46%33.75M-57.00%6.98M31.62%9.4M-6.51%8.99M-0.21%8.38M5.93%41.39M70.08%16.23M-43.65%7.14M
Selling and administrative expenses -16.04%2.47M-19.83%2.7M7.71%12.11M-2.35%3.08M1.69%2.72M4.53%2.95M30.83%3.36M33.04%11.24M29.97%3.15M19.68%2.68M
-General and administrative expense -16.04%2.47M-19.83%2.7M7.71%12.11M-2.35%3.08M1.69%2.72M4.53%2.95M30.83%3.36M33.04%11.24M29.97%3.15M19.68%2.68M
Research and development costs -18.78%4.91M-33.70%3.33M-28.31%21.54M-70.72%3.8M49.58%6.67M-11.09%6.04M-13.53%5.02M-1.88%30.04M82.35%12.98M-57.23%4.46M
Other operating expenses --------0.00%100K------------------100K--------
Operating profit 18.13%-7.36M28.16%-6.02M1.42%-30.94M68.14%-5.17M-17.62%-8.4M-2,439.02%-8.99M0.21%-8.38M19.67%-31.39M-70.08%-16.23M43.65%-7.14M
Net non-operating interest income expense
Other net income (expense) 8,824.69%20.27M-315.46%-732.88K77.84%778.49K-60.36%113.9K-18.18%97.32K665.35%227.12K19,020.18%340.15K17.55%437.75K34,353.72%287.34K7,787.93%118.95K
Other non- operating income (expenses) 8,824.69%20.27M-315.46%-732.88K77.84%778.49K-60.36%113.9K-18.18%97.32K665.35%227.12K19,020.18%340.15K17,271.03%437.75K34,353.72%287.34K7,787.93%118.95K
Income before tax 247.34%12.91M16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M44.58%-7.02M
Income tax
Net income 247.34%12.91M16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M44.58%-7.02M
Net income continuous Operations 247.34%12.91M16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M44.58%-7.02M
Minority interest income
Net income attributable to the parent company 247.34%12.91M16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M44.58%-7.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 247.34%12.91M16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M44.58%-7.02M
Basic earnings per share 225.41%18.3622.22%-0.845.41%-4.268.42%-0.72-12.50%-1.08-25,054.83%-14.6410.00%-1.0841.27%-4.44-5.56%-2.2855.56%-0.96
Diluted earnings per share 224.59%18.2422.22%-0.845.41%-4.268.42%-0.72-12.50%-1.08-25,257.23%-14.6410.00%-1.0841.27%-4.44-5.56%-2.2855.56%-0.96
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg